Emerging biomarkers show considerable promise in enriching our understanding and diagnosis of HD: these include microRNAs (miRNAs), tau protein, and 24(S)-hydroxycholesterol (24OHC), each contributing unique insights into HD’s pathophysiology [93,98,205]. Here, MAPT is linked to Huntington disease.